
Innovative Drug Brings New Hope: Beijing Children's Hospital Helps 'Ultra-Rare Child Patient' Escape 'Infusion Bag' Dependence
The General Surgery Department applied teduglutide, the world's first innovative drug for short bowel syndrome, successfully helping the child restore autonomous intestinal function and completely eliminate the need for parenteral nutrition support. This accumulates valuable clinical experience in rare disease treatment.
Beijing Children's Hospital, Capital Medical University
